NCT06108934View on ClinicalTrials.gov

A Prospective, Pre-market, Multi-center Study of Insignia Hip Stem in THA to Determine Implant Survivorship and PROMS.

NARecruitingINTERVENTIONAL
Enrollment

313

Participants

Timeline

Start Date

February 22, 2024

Primary Completion Date

March 31, 2028

Study Completion Date

December 31, 2028

Conditions
Arthritis (E.G., Degenerative Joint Disease (DJD), Osteoarthritis, and Rheumatoid Arthritis (RA))
Interventions
DEVICE

Hip stem prosthesis

The Insignia hip stem prosthesis will be used in cementless total hip replacement surgery (THA). The surgery typically takes approximately two hours. All study participants will receive the Insignia hip stem and compatible components. Experienced Orthopaedic Surgeons trained in THA will perform the surgeries as per the standard surgical technique guide for this prosthesis.

Trial Locations (1)

6008

RECRUITING

St John of God Subiaco Hospital, Subiaco

All Listed Sponsors
lead

Stryker Australia Pty Ltd.

INDUSTRY